Rocket Lab financials
$69.70−3.45%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $601.8M | $436.2M | $244.6M | $211.0M | $62.2M |
| Gross profit | $207.2M | $116.1M | $51.4M | $19.0M | -$1.9M |
| Gross margin | 34.4% | 26.6% | 21.0% | 9.0% | −3.0% |
| Operating income | -$228.8M | -$189.8M | -$177.9M | -$135.2M | -$102.1M |
| Net income | -$198.2M | -$190.2M | -$182.6M | -$135.9M | -$117.3M |
| Net margin | −32.9% | −43.6% | −74.6% | −64.4% | −188.5% |
| Diluted EPS | $-0.37 | $-0.38 | $-0.38 | $-0.29 | $-0.56 |
| EBITDA | -$184.9M | -$156.1M | -$148.2M | -$105.3M | -$91.2M |
| Operating cash flow | -$165.5M | -$48.9M | -$98.9M | -$106.5M | -$71.8M |
| Free cash flow | -$321.8M | -$116.0M | -$153.6M | -$148.9M | -$97.5M |
| Diluted shares | 530.7M | 495.9M | 481.8M | 466.2M | 209.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $828.7M | $271.0M | $162.5M | $242.5M | $691.0M |
| Short-term investments | $187.9M | $147.9M | $82.3M | $229.3M | $0.00 |
| Total debt | $168.8M | $416.5M | $120.6M | $118.5M | $100.1M |
| Total assets | $2.32B | $1.18B | $941.2M | $989.1M | $980.8M |
| Total liabilities | $602.6M | $801.9M | $386.7M | $315.9M | $224.2M |
| Shareholders' equity | $1.72B | $382.5M | $554.5M | $673.2M | $756.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology